Stay updated on Efruxifermin in NASH Subjects Clinical Trial
Sign up to get notified when there's something new on the Efruxifermin in NASH Subjects Clinical Trial page.

Latest updates to the Efruxifermin in NASH Subjects Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedUpdated the revision label from v3.0.2 to v3.2.0, indicating a newer version has been released. No other content changes observed.SummaryDifference0.1%

- Check21 days agoChange DetectedReleased a new revision (v3.1.0) and removed a related topic: MedlinePlus Genetics topic on Non-alcoholic fatty liver disease as part of the prior revision v3.0.2.SummaryDifference0.4%

- Check28 days agoChange DetectedCore content on drug safety and related topics has been removed, reducing important information about drug safety, counterfeit drugs, pharmaceutical preparations, and substandard drugs.SummaryDifference0.3%

- Check35 days agoChange DetectedAdded a MedlinePlus Genetics topic: Non-alcoholic fatty liver disease and updated the page to v3.0.2; removed the old revision tag (v3.0.1) and the Back to Top link.SummaryDifference0.5%

- Check42 days agoChange DetectedThe page has been updated to version 3.0.1, and the topic on non-alcoholic fatty liver disease has been removed.SummaryDifference0.5%

- Check49 days agoChange DetectedThe web page has been updated to include new facility and location information, as well as recent research references related to Fatty Liver Disease and drug safety. Notably, the previous location details have been removed.SummaryDifference6%

Stay in the know with updates to Efruxifermin in NASH Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efruxifermin in NASH Subjects Clinical Trial page.